Product logins

Find logins to all Clarivate products below.


: Oncology

Here you will find relevant articles and insight into all Clarivate related products and news.

These six radioligand therapy companies to watch are ushering in a new era of precision oncology These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Blog June 18, 2025
These six radioligand therapy companies to watch are ushering in a new era of precision oncology
Biopharma Clinical research Market Access
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical research Clinical trials corporate
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Clinical research Early drug development research Oncology
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
Oncology Pharma Portfolio strategy
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Clinical trials Mainland China Oncology
What to watch in the life sciences in 2024 What to watch in the life sciences in 2024
Blog December 14, 2023
What to watch in the life sciences in 2024
Oncology Pharma Portfolio strategy
Five points on CMS's first ten picks for price negotiations Five points on CMS's first ten picks for price negotiations
Blog October 25, 2023
Five points on CMS's first ten picks for price negotiations
Health policy Inflation Reduction Act IRA

Oncology

Blog August 1, 2017
HIV may be beatable using cancer’s new toolbox
Blog July 13, 2017
Checkpoint inhibitors: a cutting edge in oncology
Blog June 29, 2017
Direct-to-consumer: New avenue for PBMs could provide political shelter
Blog June 12, 2017
NGS, maybe, sort of, sometimes clinic ready
Blog May 31, 2017
Hot Topics at ASCO 2017 – Part 2
Blog May 30, 2017
CBO Score of AHCA Offers Few Surprises, Pegs 23M Loss on Insurance Rolls
Blog May 5, 2017
Don’t Expect House Health Reform to Move Far in Senate
Blog May 2, 2017
Teva Nabs First True Generic Salmeterol/Fluticasone Propionate Launch in the United States, While GlaxoSmithKline Keeps its Cool
Blog April 25, 2017
The 3 Rs of cancer research: rigor, reproducibility and robustness
Blog April 25, 2017
Health technology gadgets – good, bad or transformative?